Researcher.Life Logo

Pulmonary Therapy : Impact Factor & More

eISSN: 2364-1746pISSN: 2364-1754
JournalOpen Access

Key Metrics

CiteScore
2
SJR
Q2Respiratory Care
SNIP
0.48
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Pulmonary Therapy

Pulmonary Therapy Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher SPRINGERNATURE
Language English
Frequency Semi-annual
Article Processing ChargesEUR 4500 | USD 5600 | GBP 4100
Publication Time6
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencySemi-annual
Publication Start Year2015
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 6
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY-NC
OA statementVisit website
View less

Planning to publish in Pulmonary Therapy ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Pulmonary Therapy

Climate Change and the Impact On Interstitial Lung Diseases.
  • 26 Jan 2026
  • Pulmonary therapy
Management of Patients with Asthma, COPD, and OSA in Outpatient Unit: ACOSOU-Global Perspectives and Challenges.
  • 20 Jan 2026
  • Pulmonary therapy
Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate After Dual and Triple Therapy in Spain: A Sub-Study of the ORESTES Study.
  • 19 Jan 2026
  • Pulmonary therapy
Modeling the Potential Public Health Impact of Updated COVID-19 Vaccination Strategies in Singapore: Epidemiological Data Update.
  • 8 Jan 2026
  • Pulmonary therapy
Drug-Induced Pulmonary Toxicity in the Era of Immunotherapy and Biologics: A Narrative Review of Mechanism, Diagnosis, and Management.
  • 4 Jan 2026
  • Pulmonary therapy
Fungal-Associated Endotypes as a Treatable Trait in Bronchiectasis.
  • 29 Dec 2025
  • Pulmonary therapy
Climate Change and the Impact On Interstitial Lung Diseases.
  • 26 Jan 2026
  • Pulmonary therapy
Management of Patients with Asthma, COPD, and OSA in Outpatient Unit: ACOSOU-Global Perspectives and Challenges.
  • 20 Jan 2026
  • Pulmonary therapy
Real-World Outcomes in Patients with COPD Initiating Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate After Dual and Triple Therapy in Spain: A Sub-Study of the ORESTES Study.
  • 19 Jan 2026
  • Pulmonary therapy
Modeling the Potential Public Health Impact of Updated COVID-19 Vaccination Strategies in Singapore: Epidemiological Data Update.
  • 8 Jan 2026
  • Pulmonary therapy
Drug-Induced Pulmonary Toxicity in the Era of Immunotherapy and Biologics: A Narrative Review of Mechanism, Diagnosis, and Management.
  • 4 Jan 2026
  • Pulmonary therapy
Fungal-Associated Endotypes as a Treatable Trait in Bronchiectasis.
  • 29 Dec 2025
  • Pulmonary therapy

FAQs on Pulmonary Therapy